Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: We investigated the effect of inoculum size on MIC, bactericidal activity and the post-antibiotic effect (PAE) of carbapenems (imipenem, panipenem and meropenem) and injectable quinolones (pazufloxacin and ciprofloxacin) against Staphylococcus aureus and Pseudomonas aeruginosa, and also the relationship between in vivo systemic infection by changing the inoculum size injected in mice. RESULTS: Increasing the bacterial inoculum (10(5)-10(8) cfu/mL) had no significant effect on the MIC of any of the tested antimicrobial agents. With the standard inocula (10(6) cfu/mL) of both test strains, all the antimicrobial agents showed bactericidal activity; however, increasing the inoculum size to >10(8) cfu/mL resulted in a reduction in bactericidal activity of all the antimicrobial agents against S. aureus Smith. In contrast, increasing the inoculum size of P. aeruginosa exerted only a minimal influence on the bactericidal activity of fluoroquinolones, but resulted in a reduction in the bactericidal activity of carbapenems. With the standard inoculum size of S. aureus Smith, pre-incubation with fluoroquinolones and carbapenems, except for meropenem, was sufficient to produce PAEs. When the inoculum was increased, the duration of the PAEs of these antimicrobial agents was reduced; however, those of fluoroquinolones were longer than carbapenems. Inoculum size had a greater influence on the in vivo efficacy of carbapenems than that of fluoroquinolones. CONCLUSIONS: Our results suggest that decreased bactericidal activity, or the in vitro PAE of carbapenems and fluoroquinolones, is related to the reduced in vivo protective effect against infection caused by high inoculum with S. aureus or P. aeruginosa.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, fluoroquinolones and aminoglycoside antibiotics are less affected by the size of the inoculum because of their different mechanisms of bactericidal activity. 81,82”
Citations
Cites
File, T. M., Segreti, J., Dunbar, L., Player, R., Kohler, R., Williams, R. R., Kojak, C., & Rubin, A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.1965 · Cited by 360
Brook, I. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.361 · Cited by 241
In vitro activity of ciprofloxacin (Bay o 9867)
Fass, R. J. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.4.568 · Cited by 170
Vogelman, B., & Craig, W. A. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/15.suppl_a.37 · Cited by 153
König, C., Simmen, H. P., & Blaser, J. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.227 · Cited by 144
Craig, W. A. (1991) · Clinical Microbiology Newsletter · doi:10.1016/0196-4399(91)90030-y · Cited by 141
Carbapenems in clinical practice: a guide to their use in serious infection
Bradley, J. S., Garau, J., Lode, H., Rolston, K. V., Wilson, S. E., & Quinn, J. P. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00094-6 · Cited by 140
Postantibiotic effect of imipenem on Pseudomonas aeruginosa
Bustamante, C. I., Drusano, G. L., Tatem, B. A., & Standiford, H. C. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.5.678 · Cited by 137
Gerber, A., Brugger, H. P., Feller, C., Stritzko, T., & Stalder, B. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/153.1.90 · Cited by 122
Dosage Schedules of Antimicrobial Agents: A Historical Review
Kunin, C. M. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.1.4 · Cited by 75
Minocycline and Cefotaxime in the Treatment of Experimental Murine Vibrio vulnificus Infection
Chuang, Y.-C., Ko, W., Wang, S., Liu, J.-W., Kuo, C.-F., Wu, J.-J., & Huang, K.-Y. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.6.1319 · Cited by 69
Malanoski, G. J., Eliopoulos, G. M., Ferraro, M. J., & Moellering, R. C. (1993) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967591 · Cited by 59
Soriano, F. G., García-Corbeira, P., Ponte, C., Fernández‐Roblas, R., & Gadea, I. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.12.2686 · Cited by 52
The postantibiotic effect of meropenem and imipenem on selected bacteria
Nadler, H. L., PITKIN, D. H., & Sheikh, W. (1989) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/24.suppl_a.225 · Cited by 51
Optimal dosage of β-lactam antibiotics: time above the MIC and inoculum effect
Soriano, F. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.5.567 · Cited by 41
Ciprofloxacin Study Group, Krumpe, P. E., Cohn, S. M., Garreltes, J., Ramírez, J. A., Coulter, H., Haverstock, D. C., & ECHOLS, R. M. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.suppl_1.117 · Cited by 38
Activity of cefepime against ceftazidime-resistant Gram-negative bacilli using low and high inocula
Johnson, C. C., Livornese, L. L., Gold, M. J., Pitsakis, P. G., Taylor, S., & Levison, M. E. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.6.765 · Cited by 33
Effect of pathological changes of pH, pO2 and pCO2 on the activity of antimicrobial agents in vitro
König, C., Simmen, H., & Blaser, J. (1993) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01970957 · Cited by 33
Stearne, L. E. T., Kooi, C., Goessens, W. H. F., Bakker‐Woudenberg, I. A. J. M., & Gyssens, I. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.243-251.2001 · Cited by 17
Álvarez-Lerma, F., Calizaya, M., Pavesi, M., Vallés, J., & Palomar, M. (2001) · Medicina Clínica · doi:10.1016/s0025-7753(01)72237-3 · Cited by 10
Tsuji, A., Kaneko, Y., Yamaguchi, K., & Gotô, S. (2009) · Chemotherapy · doi:10.1159/000239214 · Cited by 4
[Staphylococcus aureus sepsis--still life threatening disease].
Kowalik, M. M., Ellert-Zygadłowska, J., Smiatacz, T., Trocha, H., Weyna, L., Orłowski, M., & Pajuro, R. (2001) · PubMed · Cited by 4
Research works printed but not linked: 1
- Bolmstrom, A., Esberg, K., Wiman, A. et al. (1996). Effects of CO2 incubation on MICs of macrolides? In Programs and Abstracts of the Thirty-sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996, Poster D38, p. 67. American Society for Microbiology, Washington, DC, USA.
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Antimicrobial Activity and Resistance: Influencing Factors
Li, J., Xie, S., Ahmed, S., Wang, F., Gu, Y., Zhang, C., Chai, X., Wu, Y., Cai, J., & Cheng, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00364 · Cited by 266
Meropenem: A Review of its Use in the Treatment of Serious Bacterial Infections
Baldwin, C. M., Lyseng-Williamson, K. A., & Keam, S. J. (2008) · Drugs · doi:10.2165/00003495-200868060-00006 · Cited by 247
Self-assembly of ciprofloxacin and a tripeptide into an antimicrobial nanostructured hydrogel
Marchesan, S., Qu, Y., Waddington, L. J., Easton, C. D., Glattauer, V., Lithgow, T. J., McLean, K. M., Forsythe, J. S., & Hartley, P. G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.096 · Cited by 227
Fernández, P., Lagaron, J. M., & Ocio, M. J. (2008) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2008.06.001 · Cited by 162
Metadata
- Authors
- Mizunaga, S., Kamiyama, T., Fukuda, Y., Takahata, M., & Mitsuyama, J.
- Corresponding author
- Mizunaga, Shingo
- ORCID
- Takahata, Masahiro
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05-12
- Volume
- 56
- Issue
- 1
- Pages
- 91-96
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2162909214
- Semantic Scholar
- 65aaabf2980c730a535b1152de5bf9cb289bc76f
- Cited by
- 78
- References
- 22
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2022: 8 · 2021: 6 · 2020: 1 · 2019: 4 · 2018: 3 · 2017: 8 · 2016: 3 · 2015: 6 · 2014: 2 · 2013: 7 · 2012: 3
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- inoculum size, Staphylococcus aureus, Pseudomonas aeruginosa, fluoroquinolones, carbapenems, imipenem, panipenem, meropenem, pazufloxacin, ciprofloxacin, minimum inhibitory concentration, bactericidal activity, post-antibiotic effect, in vivo efficacy, systemic infection, mice
- MeSH terms
- Animals, Ciprofloxacin, Male, Mice, Inbred ICR, Microbial Sensitivity Tests, Oxazines, Pseudomonas aeruginosa, Pseudomonas Infections, Staphylococcal Infections, Staphylococcus aureus, Carbapenems, Fluoroquinolones, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.